Document is current
Any future updates will be listed below
-
Authors
Herrmann, Ester J.
Lange, Denise
Hannig, Jennifer
Zimmer, Gina
Gruen, Dimitri
Keller, Till
Edegran, Albin
Johnson, Linda S.
Sossalla, Samuel
Guckert, Michael
Assmus, Birgit https://orcid.org/0000-0003-2658-6444
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (SFB 1213)
Deutsche Forschungsgemeinschaft (Project B09)
Justus-Liebig-Universität Gießen
- License Information
-
More Information
Article History
Received: 5 May 2024
Accepted: 16 October 2024
First Online: 7 November 2024
Declarations
:
: BA received speaker’s/consultancy honoraria from Abbott, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers-Squibb, Edwards, Novartis, NovoNordisk, Pfizer, CSL Vifor and ZOLL. EJH reports receiving lecture fees from Bayer and CSL Vifor. SS received speaker’s/consultancy honoraria from Boehringer Ingelheim GmbH, Astra Zeneca, Novartis (additional research grant), Berlin-Chemie, Menarini, Bristol-Myers-Squibb, Amgen. LSJ receives consulting fees from MEDICALgorithmics.
: The study was conducted according to the guidelines of the Declaration of Helsinki, and was approved by the Ethics Committee of the Medical Faculty, Justus Liebig University Giessen, Germany, (protocol number AZ138/19, Amendment April 16, 2020).
: Informed consent was obtained from all subjects involved in the study. Written informed consent was provided by the patients to publish the results of this study.
